ROME – In the quest for successful glaucoma surgery, antimetabolites are more commonly being used, but they are a mixed blessing, according to a speaker here.
Author: OphthalmologyWeb
Visual Fields Reference Work From Richmond Products
Albuquerque, NM – 23 May 2011. Richmond Products Inc. announces the availability of a major reference publication that documents analyses of visual field disorders identifying the unique aspects of disease or other causes. The book is exceptionally det…
FDA Schedules Advisory Committee Meeting To Discuss BLA For VEGF Trap-Eye For The Treatment Of Wet Age-Related Macular Degeneration
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the company that it has scheduled a Dermatologic and Ophthalmic Drugs Advisory Committee Meeting to be held on June 17, 2011 to discuss the Co…
Femtosecond Laser Technology Will Likely Be Integrated Into An Increasing Number Of Procedures
Femtosecond laser technology has been fully integrated in refractive, corneal and scleral surgery and is likely to be the future of cataract surgery, according to Richard L. Lindstrom, MD, speaking at the annual joint meeting of Ocular Surgery News and…
Femtosecond Laser Technology Will Likely Be Integrated Into An Increasing Number Of Procedures
Femtosecond laser technology has been fully integrated in refractive, corneal and scleral surgery and is likely to be the future of cataract surgery, according to Richard L. Lindstrom, MD, speaking at the annual joint meeting of Ocular Surgery News and…
UCSB Scientists Make Strides In Vision Research
(Santa Barbara, Calif.) — New research at UC Santa Barbara is contributing to the basic biological understanding of how retinas develop. The study is part of the campus’s expanding vision research.
Michael R. Redmond, MD, Receives Outstanding Advocate Award From The American Academy Of Ophthalmology
The American Academy of Ophthalmology (Academy) has presented the Outstanding Advocate Award to Michael R. Redmond, MD, for his more than 30 years of involvement with advocacy on behalf of ophthalmologists and their patients and for his many contributi…
Boatright Begins Term As ARVO President
Jeffrey H. Boatright, PhD, FARVO (Emory University School of Medicine) is the new president of the Association of Research in Vision and Ophthalmology (ARVO). He succeeds J. Mark Petrash, PhD, FARVO (University of Colorado), whose one-year term ended i…
Smoking Strongly Linked To Age-Related Blindness
When Kern and Harbach wrote “Smoke Gets in Your Eyes” nearly 80 years ago, they were playing bards, not doctors. But a new study shows that smokers are at substantially increased risk for developing age-related blindness.
Michael R. Redmond, MD, Receives Outstanding Advocate Award From The American Academy Of Ophthalmology
The American Academy of Ophthalmology (Academy) has presented the Outstanding Advocate Award to Michael R. Redmond, MD, for his more than 30 years of involvement with advocacy on behalf of ophthalmologists and their patients and for his many contributi…
Wills Eye Institute, Thomas Jefferson University Establish New Vision Research Center
Wills Eye Institute and Thomas Jefferson University have partnered to create the Wills Vision Research Center at Jefferson here, according to a press release.
Michael R. Redmond, MD, Receives Outstanding Advocate Award From The American Academy Of Ophthalmology
The American Academy of Ophthalmology (Academy) has presented the Outstanding Advocate Award to Michael R. Redmond, MD, for his more than 30 years of involvement with advocacy on behalf of ophthalmologists and their patients and for his many contributi…
Boatright Begins Term As ARVO President
Jeffrey H. Boatright, PhD, FARVO (Emory University School of Medicine) is the new president of the Association of Research in Vision and Ophthalmology (ARVO). He succeeds J. Mark Petrash, PhD, FARVO (University of Colorado), whose one-year term ended i…
Boatright Begins Term As ARVO President
Jeffrey H. Boatright, PhD, FARVO (Emory University School of Medicine) is the new president of the Association of Research in Vision and Ophthalmology (ARVO). He succeeds J. Mark Petrash, PhD, FARVO (University of Colorado), whose one-year term ended i…
Michael R. Redmond, MD, Receives Outstanding Advocate Award From The American Academy Of Ophthalmology
The American Academy of Ophthalmology (Academy) has presented the Outstanding Advocate Award to Michael R. Redmond, MD, for his more than 30 years of involvement with advocacy on behalf of ophthalmologists and their patients and for his many contributi…
Boatright Begins Term As ARVO President
Jeffrey H. Boatright, PhD, FARVO (Emory University School of Medicine) is the new president of the Association of Research in Vision and Ophthalmology (ARVO). He succeeds J. Mark Petrash, PhD, FARVO (University of Colorado), whose one-year term ended i…
Paramax Moves Closer To FDA Approval
Paradigm Medical Industries, Inc. (OTC.PK: PDMI) announced today that it had received notification from its Italian partner, Costruzione Strumenti Oftalmici (CSO), which manufactures the Paramax, that it has provided 26 pages and 24 attachments to the …
New Multidisciplinary Center Takes Innovative Approach To Vision Research
Wills Eye Institute and Thomas Jefferson University Establish the Wills Vision Research Center at Jefferson
New Multidisciplinary Center Takes Innovative Approach To Vision Research
Wills Eye Institute and Thomas Jefferson University Establish the Wills Vision Research Center at Jefferson
New Multidisciplinary Center Takes Innovative Approach To Vision Research
Wills Eye Institute and Thomas Jefferson University Establish the Wills Vision Research Center at Jefferson